Surveys on Coxiella burnetii infections in Swedish cattle, sheep, goats and moose
© Ohlson et al.; licensee BioMed Central Ltd. 2014
Received: 20 December 2013
Accepted: 10 June 2014
Published: 9 July 2014
Skip to main content
© Ohlson et al.; licensee BioMed Central Ltd. 2014
Received: 20 December 2013
Accepted: 10 June 2014
Published: 9 July 2014
Q fever is a zoonotic disease caused by the bacterium Coxiella burnetii. Prevalence data in ruminant species are important to support risk assessments regarding public and animal health. The aim was to investigate the presence of or exposure to C. burnetii in cattle, sheep, goats and moose, and to compare two enzyme-linked immunosorbent assays (ELISAs). National surveys of antibodies against C. burnetii were performed for dairy cattle (n=1537), dairy goats (n=58) and sheep (n=518). Bovine samples consisted of bulk milk, caprine of pooled milk, and ovine of pooled serum. Antibodies were investigated in moose samples (n=99) from three regions. A one-year regional cattle bulk milk survey was performed on the Isle of Gotland (n=119, four occasions). Cattle, sheep and goat samples were analysed with indirect ELISA and moose samples with complement fixation test. For the sheep, goat, and parts of the cattle survey, samples were run in parallel by ELISAs based on antigens from infected ruminants and ticks. Bulk milk samples from the regional cattle survey and vaginal swabs from a subset of the sheep herds (n=80) were analysed for the agent by polymerase chain reaction. Spatial clustering was investigated in the national cattle survey.
The prevalence of antibodies in dairy herds was 8.2% with large regional differences. High risk clusters were identified in the southern regions. The prevalence among dairy herds on the Isle of Gotland varied from 55.9% to 64.6% and 46.4% to 58.9.0% for antibodies and agent, respectively, overall agreement between agent and antibodies was 85.2%. The prevalence of antibodies in sheep was 0.6%, the agent was not detected the vaginal swabs. Antibodies were not detected in goats or moose, although parts of the moose samples were collected in an area with high prevalence in cattle. The overall agreement between the two ELISAs was 90.4%.
The prevalence of antibodies against C. burnetii in dairy cattle in Sweden shows large regional differences. The results suggest that C. burnetii is a rare pathogen among Swedish moose, dairy goat and sheep. ELISAs based on ruminant and tick antigen performed in a similar manner under Swedish conditions.
Coxiella burnetii, the cause of Q fever, is present in domestic and wild ruminants worldwide [1–6]. The presence of C. burnetii in domestic animal populations in Sweden is known since the early 1990’s, when the bacterium was first isolated from a sheep placenta . In 1993, national abattoir surveys on Swedish sheep and cattle showed a low seroprevalence; 0.3% in sheep (n = 1001) and 1.3% in cattle (n = 784) . The presence of C. burnetii in the Swedish goat population had not been investigated nor have studies been performed in wild ruminants.
Antibodies against C. burnetii are usually detected by enzyme-linked immunosorbent assays (ELISAs), indirect immunofluorescence (IFA) or by the complement fixation test (CFT). ELISAs, however, are preferred for practical reasons and for their higher sensitivity . ELISAs based on antigens prepared from a ruminant isolate have been described as more sensitive than those based on antigens isolated from ticks, when assessed on goat sera . Also, in scientific reports submitted to the European Food Safety Authority (EFSA) ELISAs using C. burnetii antigens prepared from ruminant isolates are recommended [11, 12].
Prevalence data of C. burnetii infection in different ruminant species are important to support risk assessments or decisions on preventive measures regarding public and animal health. This study presents a series of investigations into the presence of C. burnetii in Swedish cattle, sheep, goats and moose. Also, a comparison of two ELISAs for the detection of antibodies against C. burnetii in cattle, sheep and goats is reported.
This study is based on five surveys done in Sweden: 1) a national survey of cattle dairy herds, 2) a regional survey of cattle dairy herds, 3) a national survey of goat dairy flocks, 4) a national survey of sheep flocks and 5) a regional survey of wild moose. Details on each of these surveys are presented below.
The prevalence of antibodies to C. burnetii among dairy herds was determined in a national bulk milk survey conducted in November 2008 and in June 2009. Samples were based on milk submitted for testing within the national control scheme for bovine viral diarrhoea virus, where >95% of all Swedish dairy cattle herds were included. Herds in the scheme were sampled as part of the routine milk quality testing, where samples are collected in test tubes containing Bronopol (2-bromo-2-nitropropane-1.3-diol). The samples were forwarded to the National Veterinary Institute (SVA), Uppsala, Sweden for antibody testing after the milk quality testing had been done. Every fourth milk sample was randomly selected for antibody testing. In total, samples from 1537 herds were analysed for antibodies to C. burnetii (2008: n = 1000; 2009: n = 537), corresponding to 26% of the Swedish dairy cattle herds (2009: n = 6020) . There was no overlap in the herds selected in 2008 and 2009.
Herds that were antibody positive in 2008 (n = 85) were invited to participate in a follow up study in 2009 and 41 agreed to participate. Bulk milk from these herds was tested for antibodies and C. burnetii antigen. The follow up group had a similar distribution of the level of antibodies in the bulk milk when compared to the entire group of positive herds (S/P ratio =110.9 (SD 31.6) vs 106.7 (34.4)) and they were also geographically representative of the sampling frame. Bulk milk samples were collected directly from the tank by the farmer who was instructed to collect the sample at the end of the milking, when all lactating cows had contributed to the bulk milk.
The presence of antibodies and C. burnetii DNA in the Swedish dairy goat population was investigated during May-September 2010. Swedish goat farmers were identified through the National Sheep and Goat Register, where all holdings of goats must be registered. All farmers in the register with ≥ 10 goats (n = 205) were invited to participate. As the target population was dairy goats, farmers were also asked to state the type of goats they held and to respond irrespective of if they had dairy goats or not. In all, 92 farms held dairy goats and 58 of these agreed to participate (63%). Farmers were asked to collect milk from all lactating goats, either by sampling from the bulk tank or by manually collecting milk from each goat in a container before transfer to a sampling tube. A questionnaire was administered to collect information about herd size, the number of lactating goats and contact with sheep and cattle. The milk samples were sent to SVA, where they were analysed for antibodies and for presence of C. burnetii DNA.
A national survey was performed in 2010 to determine the seroprevalence of antibodies to C. burnetii in the Swedish sheep population. The flocks were selected among flocks tested within the national maedi-visna programme; these were geographically representative of all sheep flocks affiliated to the scheme, which covers approximately 75% of the Swedish sheep population. All sheep holders must be registered in the National Sheep and Goat Register. Of a total of 819 herds sampled in the maedi-visna programme in 2010, only herds with ≥ 10 sampled animals were included in the C. burnetii survey (n = 510). The serum samples were pooled by herd before analysis at SVA, with 10 individuals per pool. In addition, sera were analysed individually for 54 flocks. These were purposively selectedas positive or weakly positive herds in the pooled testing (n = 3) as well as 51 negative herds, preferentially those that were borderline or from geographical areas where C. burnetii was known to be prevalent in cattle (based on cattle surveys in 2008-2009).
A subset of the sheep flocks included in the national survey was further investigated for C. burnetii DNA in 2011. Eighty herds were randomly selected from two different strata, representing different risks of having C. burnetii infection; 1/3 from areas where the prevalence of antibodies against C.burnetii was high among cattle in the 2008-2009 national bulk milk survey (Southern Sweden, incl. the Isle of Gotland) and 2/3 from other parts of Sweden. The farmers were instructed to take vaginal swabs during lambing, using Amies agar gel swabs without charcoal (Copan Venturi Transystem®, Copan Diagnostics Inc., Corona, USA). Samples were stored on the farm at around 5°C for up to 10 days until 10 sheep had lambed and were then shipped to SVA by mail. The samples were pooled by herd, before analysis for the presence of C. burnetii DNA.
Sampling of moose was carried out as a part of a study addressing reproduction and health of moose in southern Sweden. During the first week of the moose hunting season (starting on the second Monday of October each year) in 2008-2010, post mortem blood samples were collected from shot subadult and adult moose in two areas in southern Sweden (mainland) and on the Isle of Öland (Figure 1). Dairy and sheep farms are highly abundant on the Isle of Öland, whereas the mainland moose sampling regions have a lower herd density. Hunters were advised to call field personnel immediately after the moose was shot, and blood from the heart or the caudal vena cava was collected. The blood was transported to a nearby field laboratory where it was centrifuged and stored at -20°C until analysis. Data on sex and age were recorded. Age determination of moose was performed with a previously described method , where the first molar was sectioned and cementum layers counted. Subadults were defined as 1.5 year old, and all moose older than 1.5 years were defined as adults.
After arrival at SVA, serum and milk samples were stored at -20°C and vaginal swabs at -70°C until analysis. Analyses for antibodies to C. burnetii in cattle, sheep and goats were performed using commercially available indirect ELISAs according to the manufacturers’ instructions. For the national and regional cattle bulk milk surveys, samples were analysed using CHEKIT Q Fever Antibody ELISA Test Kit (Idexx, Liebefeld-Bern, Switzerland), which is based on tick-derived C. burnetii antigen (Nine Mile strain). For the first sampling in the regional dairy cattle herd survey on the Isle of Gotland, the national goat survey, and the national sheep survey, the samples were run in parallel by CHEKIT Q Fever Antibody ELISA Test Kit and ELISA Cox kit (LSI-Laboratoire Service International, Lyon, France) based on antigen obtained from a C. burnetii strain isolated from sheep.
The definition of a positive sample was set according to the manufacturers’ instructions; for CHEKIT Q Fever >40 (weak positive >30 to <40), and for ELISA Cox > 40 for serum and individual milk samples and >30 for pooled milk samples. The serum samples were analysed at a dilution of 1:400 for both tests and individual and pooled milk samples were analysed by ELISA Cox at a dilution of 1:20 and by CHEKIT Q Fever at 1:5. Sensitivity of both tests is 100, and specificity 95 and 100 for ELISA Cox and CHEKIT Q Fever, respectively according to the manufacturers (Jose Hurst (LSI) and Geert Baele (Idexx), personal communications). In an investigation by Horigan et al.  the sensitivity was estimated to 87.0 and 98.6, and the specificity to 99.1 and 97.1 for ELISA Cox and CHEKIT Q Fever respectively. To our knowledge, there are no estimations available regarding sensitivity and specificity for pooled samples.
For detection of C. burnetii in the national cattle bulk milk survey, a commercial polymerase chain reaction (PCR) kit was used (Adiavet Cox PCR detection kit, Adiagene, Saint Brieuc, France). For the regional bulk milk survey of dairy herds on the Isle of Gotland, the national goat survey as well as the vaginal swab survey in sheep, an in-house real-time PCR protocol was used (Swedish Institute for Communicable Disease Control; Talar Boskani, personal communication). The two PCR protocols performed equally well when evaluated in an interlaboratory comparison of real-time PCR methods to detect C. burnetii .
Moose sera were analyzed with a complement fixation test (CFT). The CFT was based on the protocol described in the World Organization for Animal Health (OIE) Manual of Standards  and used antigen produced in monkey kidney tissue culture. The CFT detects both phase I and phase II antibodies, and a cut-off titre of 1:10 was used. Thus, all titres of ≤ 1:10 were considered negative in accordance with OIE standards.
True prevalence was calculated as: (apparent prevalence + specificity - 1)/(sensitivity + specificity - 1). Concordance between ELISACox and CHEKIT Q Fever results as well as between CHEKIT Q Fever and PCR results was calculated as percent agreement and estimated by Cohen’s kappa value.
Spatial clustering of test-positive and test-negative herds in the national bulk milk survey was investigated using the spatial scan statistic (M. Kulldorff and Information Management Services, Inc. SaTScan™ version v9.1.1; http://www.satscan.org, 2011). Location of herds was based on geographical coordinates retrieved from the database of the Swedish Board of Agriculture. The testing was performed using a Bernoulli model  where the test-positive herds were considered cases and test-negative herds were considered controls. To be able to map a reasonable number of clusters, and clusters of reasonable extent, different input for maximum cluster size (50%, 25%, 15% and 5% of the population at risk, i.e. all sampled herds) and different cluster shapes (circular or elliptic) were attempted. In the spatial scan, the observed number of cases within each potential cluster is compared to the expected number, and the relative risk of cases within the cluster compared to outside the cluster is calculated. Whether the risk is significantly higher or lower within the cluster area compared to other areas is tested by comparing the maximum likelihood from the real dataset with maximum likelihoods from the same analysis on random replications of the data (Monte Carlo hypothesis testing, 9,999 permutations). Visualization of cluster analysis output was made using ArcMap™ version 10.0 (ESRI Inc., Redlands, CA, USA).
Statistical analyses, except for cluster analyses, were performed using the statistical software Stata (Stata statistical software: Release 12.1; College Station, TX, USA: StataCorp LP).
The overall prevalence of dairy herds with antibodies to C. burnetii in bulk milk was 8.2% (95% confidence interval (CI) 6.9-9.7%) and the true prevalence was 7.9% based on the sensitivity and specificity determined by Horigan et al. . There were large regional differences with highest prevalence on the Isles of Gotland and Öland (59% and 35%, respectively). Since the prevalence on the Isle of Gotland exceeded the highest prevalence on the continent, Gotland was selected for the regional survey. Eighty-five dairy herds were antibody positive in the 2008 bulk milk survey (8.5%) and 41 in 2009 (7.6%). The result of the national survey is shown in Figure 1.
Of the 85 herds that were antibody positive in 2008, 41 submitted a new bulk milk sample in 2009 for ELISA and PCR testing. The sampling was conducted 7 to 11 months after the initial test in 2008. Thirty-five herds (85%) were still antibody positive and C. burnetii DNA was detected in 29 of these (83%). Of the six antibody negative herds, one was PCR-positive. The PCR positive herds were all located in southern Sweden (counties of Halland, Skåne, Blekinge, Kalmar and Isle of Gotland).
Prevalence repeated sampling
(56.6 – 66.2)
(48.4 – 67.2)
(57.8 – 67.6)
(47.3 – 65.5)
(50.8 – 61.0)
(46.0 – 64.3)
(55.6 – 73.6)
(49.7 – 68.2)
Incidence repeated sampling
September 2010 – January 2011
January 2011 – June 2011
June 2011 – October 2011
In total, 453 bulk milk samples were analysed for both antibodies and C. burnetii DNA; 51.6% were positive for both antibody and DNA, 33.6% were consistently negative for both antibody and DNA, 9.3% were antibody positive but DNA negative and 5.5% were antibody negative but DNA positive. The overall agreement between findings of both antibodies and DNA in the bulk milk was 85.2%, with a corresponding kappa value of 0.69, indicating substantial agreement .
Antibodies parallel analysis
CHEKIT Q fever
C. burnetii DNA was not detected in bulk milk from any of the 58 dairy goat flocks. Also, all investigated flocks were bulk milk antibody negative in the CHEKIT Q fever ELISA kit, whereas one herd, located in the county of Västerbotten, showed a reaction in the ELISACox kit. If the reaction would be counted as a true positive, this would correspond to an antibody prevalence of 1.7% (95% CI 0.04-9.2%) for the ELISACox test, with a true prevalence of 0.4% based on the estimations of sensitivity and specificity by Horrigan et al. . The median flock size was 38 adult animals (9, 118; 5th, 95th percentile) and the median number of lactating goats was 24 (6, 84). Contacts with sheep and cattle were reported by 16 (32%) and 19 (37%) of responders (n = 51 and 52), respectively.
Antibodies against C. burnetii were detected in three of 518 sheep flocks (0.6%; 95% CI 0.1-1.7%), by one or both ELISAs; one herd was positive in both assays, one was positive only in ELISACox, and one was weakly positive only in the CHEKIT Q fever. The true prevalence calculated from the apparent prevalence of 0.4% (95% CI 0.1-1.4%; two positive in each test out of 518 herds) was 0% for both ELISAs based on the estimations of sensitivity and specificity by Horigan et al. . The analysis of individual samples revealed single positive animals in the two positive pools, and two weakly positive animals in the weakly positive pool. Of the 51 negative pools, two included one positive animal, and they were both only positive in one of the two tests. Herds where antibodies were detected either in pooled analysis or among individual samples were located in the counties of Gotland, Uppsala and Jönköping. C. burnetii DNA was not detected in any of the 80 pooled vaginal swab samples.
Sampling of moose
Subadults (≤1.5 years)
Adults (>1.5 years)
Reports indicate that Sweden has a low incidence of clinical cases of Q fever in humans. In Sweden, up until 2007 only two domestic human cases had been described, in the 1980’s and 90’s . In the 1990’s, a Swedish survey in humans identified 28% of sheep farmers and 13% of veterinarians to be antibody positive, indicating a larger extent of the exposure . Since Q fever became a notifiable disease in humans in 2004 , one domestic case was reported in 2007 . In 2008, eight domestic cases of Q fever in humans were reported based on serological evidence of recent exposure, all linked to a follow-up of contacts with a cattle herd with reproductive disorders . The information regarding animals is sparse as very few investigations have been carried out. However, since Q fever in both humans and animals is mostly asymptomatic, its occurrence is likely to be underreported. Thirty-seven cases have been notified in cattle from 2001 to 2011 . However all were reported after 2008 and mainly as a result of follow-up of the surveys reported in this paper. A targeted testing of aborted bovine fetuses carried out in 2010 did not reveal any cases positive for C. burnetii .
The prevalence of antibodies against C. burnetii in Swedish dairy herds varied depending on geographical region. High risk clusters were in general located in the south, which was expected since herd density is highest here. An interesting observation was that low risk clusters were identified not only in the north, were herd density is low, but also in areas in the middle parts of the Sweden were herd density is high. In a Danish survey, there was no association found between regional dairy herd density and prevalence of antibodies against C. burnetii in bulk tank milk . Wind is known to play an important role in C. burnetii transmission  and the high risk clusters areas identified in the present study tended to be geographically located in more windy areas than the low risk clusters . The longitudinal investigation on the Isle of Gotland showed that there was a high prevalence on each sampling occasion, i.e. in all seasons, both when considering detection of antibodies as well as C. burnetii DNA. Also, there were conversions from bulk milk negative to positive, regarding both antibodies and DNA. In the present study there was a seasonal variation in antibody titer; lower in the winter (indoor/stable season) compared to the summer (outdoor/pasture season). Grazing or contact through the fence with other ruminant herds has been shown to be associated with a higher within-herd seroprevalence , and the level of antibodies in bulk milk has a connection to the within-herd seroprevalence, particularly as the lowest level of antibodies was associated with the lowest mean of within-herd prevalence .
Swedish goats were for the first time examined for C. burnetii exposure. The results suggest that C. burnetii is a rare pathogen in this population. Swedish dairy goat flocks are largely located in the northern part of the country, where the prevalence of C. burnetii exposure in cattle was low as well. This may indicate similarities between the species with regard to the distribution of risk factors for transmission and persistence in this part of the country. However, it is surprising that the exposure level in sheep seems to be very low as the bacterium was indeed cultured from sheep in Sweden in the 1990’s . To validate the apparent absence of exposure seen in the serological survey, the findings were followed up by screening sheep herds for vaginal C. burnetii excretion. The result confirmed that the prevalence of C. burnetii in the Swedish sheep population is likely to be very low. Still, previous studies indicate that sheep farmers have a higher prevalence of antibodies to C. burnetii than both veterinarians and control populations . However, it is not known from those studies to what extent farmers were also exposed to cattle. Further studies on C. burnetii in the sheep and goat populations on the Isles of Öland and Gotland would be interesting, since the prevalence among cattle is high in these areas.
Since the cattle bulk milk survey on the Isle of Öland showed a high prevalence, we expected to find some seropositive moose in the area. This was not the case, although moose sometimes browse in the vicinity of livestock pasture. However, this mostly concerns beef cattle and not dairy cattle that generally graze closer to the farms where moose rarely are abundant. The status regarding C. burnetii exposure in Swedish beef cattle is still unknown. Furthermore, the density of the moose population on Isle of Öland is lower than on the mainland, i.e. two to three moose per 1,000 hectares (Magnus Johansson, personal communication) (250 – 300 moose on the whole island). On the mainland of Sweden, population density sometimes exceeds 12-14 moose per 1,000 hectares . It would have been interesting to investigate the prevalence among wild ruminants on the Isle of Gotland since that was the county with the highest prevalence among dairy cattle herds; however, moose are not present there. The diagnostic method used in this study, CFT, is not validated for cervids in general and moose in particular and there is a risk of false negative results. In general, the CFT is considered to be less sensitive when compared to currently available commercial ELISAs , at least in the species for which it is validated. However, based on our results, we do not consider moose to be a potential reservoir or source of C. burnetii infection for domestic animals or humans in Sweden. Serological investigations of other cervids (including grazers) with a higher local and regional abundance, such as roe deer (with densities exceeding 100 animals per 1,000 hectares), and the development of a validated analysis could revise this conclusion.
The reason for using two parallel ELISAs in the investigations was the suggestions from the literature that assays based on antigen from C. burnetii isolated from ruminants rather than ticks may be more sensitive [10, 12]. However, this was not found under Swedish conditions, where the two tests performed in a similar manner in sheep and goats, and where the kit with C. burnetii antigen of ruminant origin was, if anything, less sensitive in Swedish cattle.
In the cattle surveys, there was a consistently high correlation between presence of antibodies and detection of the agent. Although the correlation is not perfect, this indicates that bulk milk screening of antibodies can be used as a convenient tool for monitoring Q fever infection in cattle, at least under Swedish conditions.
In Sweden, veterinary and human authorities have jointly issued recommendations directed towards people in contact with herds likely or known to be infected with C. burnetii. These include advice on hygienic measures to reduce exposure to potentially infectious materials for both animals and people (e.g. separate calving area, cleaning and disinfection of calving area, secure disposal of placentas and aborted fetuses, etc.), and also to identify work tasks associated with a higher risk of exposure.
The prevalence of antibodies against C. burnetii in Swedish dairy cattle shows large regional differences. The results suggest that C. burnetii is a rare pathogen in the Swedish moose, goat and sheep populations. ELISAs based on sheep and tick derived C. burnetii antigen performed in a similar manner under Swedish conditions.
The authors wish to acknowledge Linda Svensson for visualization of the geographical extent of the surveys (Figure 1). The cattle surveys were financially supported by the Board of Agriculture, by Sällskapet för Veterinärmedicinsk Forskning and by CF Lundström’s Foundation. The sheep and goat surveys were funded by the Board of Agriculture. The part on moose received financial support from the Swedish Environmental Protection Agency, the Environmental monitoring and assessment program at the Swedish University of Agricultural Sciences, and the Wildtech Project (European Union Seventh Framework Programme (FP7/2007-2013) grant agreement no. 222633).
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.